United States Supports World Tuberculosis Day Event in Durban

Each year we commemorate World TB Day on March 24 to raise public awareness about the devastating health, social and economic consequences of tuberculosis (TB) and to step up efforts to end the global TB epidemic. The date marks the day in 1882 when Dr. Robert Koch announced that he had discovered t

Press Release | March 23, 2018

The U.S. Consul General to Durban, Sherry Zalika Sykes, attended South Africa’s World Tuberculosis (TB) event on March 21, in Cato Manor, Durban.  The event was co-sponsored by the United States and attended by Deputy President David Mabuza, His Majesty King Goodwill Zwelithini, Minister of Health Dr. Aaron Motsoaledi, and other high-ranking officials from the KZN Provincial Government and eThekwini Municipality.

The U.S. government supports South Africa’s National TB Control Program through the U.S. President’s Plan for AIDS Relief (U.S. PEPFAR), implemented by the United States Agency for International Development (USAID) and the U.S. Centers for Disease Control and Prevention (CDC), as well as through our substantial support to the Global Fund to Fight AIDS, TB, and Malaria.

In addition to our U.S. PEPFAR investment, USAID is working closely with the National Department of Health to implement a $65 million, five-year TB assistance project.

“I’m proud that the U.S. government and many other development partners have been strong partners with South Africa in the fight against TB.  From government leaders, to health practitioners, to amakhosi and the Zulu king himself, I heard a very strong call to combat TB and to approach community health in a holistic way,” Consul General Sykes said of the event.

“We need leaders like them in each and every province to spearhead the fight against TB; to engage with the TB patients and the front-line workers fighting for the success of TB prevention and treatment efforts.  We are pleased that the U.S. government partnership with the South African Government in research is flourishing, and resulting in new innovations in health service delivery.  Our collaborative research programs, including those supported by the U.S. National Institutes of Health and USAID, address priority issues from new TB drug regimens to HIV vaccines, which have global implications.  We will continue to partner because, despite great success, there is still much to do,” Sykes added.

For more information: Caroline Schneider: USEmbassySAPress@state.gov